BDBM13640 3-Oxybenzamide 26::4-bromo-3-[2-(2,4-dichlorophenyl)ethoxy]-N-{[1-(pyridin-4-yl)piperidin-4-yl]methyl}benzamide

SMILES Clc1ccc(CCOc2cc(ccc2Br)C(=O)NCC2CCN(CC2)c2ccncc2)c(Cl)c1

InChI Key InChIKey=ADLCQQQYJWNTLY-UHFFFAOYSA-N

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 13640   

TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM13640(3-Oxybenzamide 26 | 4-bromo-3-[2-(2,4-dichlorophen...)
Affinity DataKi:  76nMAssay Description:Inhibitory activity against human Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM13640(3-Oxybenzamide 26 | 4-bromo-3-[2-(2,4-dichlorophen...)
Affinity DataKi:  76nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed